Researchers evaluate possible mitochondrial factors in Alzheimer’s pathogenesis

A group of authors critically evaluated and interpreted the evidence linking mitochondrial dysfunction and metabolic changes to the pathogenesis of Alzheimer’s disease (AD).

Spero’s stock slides after antibiotic flops in Phase II trial

Spero’s SPR729 is a prodrug that converts into an active form that targets ATPase site of DNA gyrase B in mycobacteria. Image credit: Lemonsoup14 /

October 30, 2024

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec (news with additional features) – Biotech Investments

Issuer: Immunic AG / Key word(s): Personnel 24.07.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc. Strengthens

July 25, 2024

Sexual and Gender Minorities Twice as Likely to Report Epilepsy

Individuals who identified with a sexual or gender minority were more than twice as likely to report having epilepsy compared with the general population, survey

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.